Lured By Its Discovery Platform And Pipeline, Amgen Bids For Nuevolution

 
• By Sten Stovall
Fish
Amgen’s $166.8m Offer Backed By Nuevolution Board And Key Shareholders • Source: Shutterstock

More from Business

More from Scrip